{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:44:15Z","timestamp":1793400255495,"version":"4.5.0"},"reference-count":53,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi241073-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>The incidence of severe maternal morbidity (SMM)\u2014and particularly cardiovascular SMM (cvSMM), the first cause of pregnancy-related mortality\u2014has been rising in North America. Although hypertensive disorders of pregnancy (HDP) are common, their association with cvSMM specifically remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi241073-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess the association between individual subtypes of HDP and cvSMM, in addition to overall SMM, in a large, nationally representative sample.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi241073-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>A population-based cohort study using the United States National Inpatient Sample was conducted. Individuals with obstetric deliveries between 2015 and 2019 were included. Data analysis was performed from October 2023 to February 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi241073-7\">\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>HDP subtypes included gestational hypertension, chronic hypertension, preeclampsia without severe features, severe preeclampsia, and HELLP (hemolysis, elevated liver enzymes, and low platelet) syndrome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi241073-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was a composite of cvSMM (including conditions such as pulmonary edema, stroke, and acute myocardial infarction) and the secondary outcome was a composite of overall SMM (including cvSMM and other conditions such as respiratory failure, severe postpartum hemorrhage, and sepsis). Adjusted risk ratios (aRRs) for the association between HDP subtypes and the outcomes were estimated using modified Poisson regression models adjusted for demographic and clinical characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi241073-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 15\u202f714\u202f940 obstetric deliveries, 2\u202f045\u202f089 (13.02%) had HDP, 23\u202f445 (0.15%) were affected by cvSMM, and 282\u202f160 (1.80%) were affected by SMM. The mean (SD) age of the cohort was of 29 (6) years. The incidence of cvSMM was higher in participants with HDP than those without HDP (0.48% [9770 of 2\u202f045\u202f089] vs 0.10% [13\u202f680 of 13\u202f669\u202f851];\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). Participants with HELLP syndrome had the highest risk for cvSMM (aRR, 17.55 [95% CI, 14.67-21.01]), followed by severe preeclampsia (aRR, 9.11 [95% CI, 8.26-10.04]), and chronic hypertension (aRR, 3.57 [95% CI, 3.15-4.05]). Although HDP subtypes were also associated with overall SMM, the association with HELLP syndrome (aRR, 9.94 [95% CI, 9.44-10.45]), severe preeclampsia (aRR, 3.66 [95% CI, 3.55-3.78]), and chronic hypertension (aRR, 1.96 [95% CI, 1.88-2.03]) was attenuated compared with cvSMM.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi241073-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this cohort study, a graded relationship by severity characterized the association between HDP and cvSMM. Although all HDP subtypes were associated with an increased risk of overall SMM, the risk was more pronounced for cvSMM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.36478","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T11:32:14Z","timestamp":1727955134000},"page":"e2436478","source":"Crossref","is-referenced-by-count":30,"title":["Hypertensive Disorders and Cardiovascular Severe Maternal Morbidity in the US, 2015-2019"],"prefix":"10.1001","volume":"7","author":[{"given":"Isabelle","family":"Malham\u00e9","sequence":"first","affiliation":[{"name":"Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada"},{"name":"Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Nerenberg","sequence":"additional","affiliation":[{"name":"Departments of Medicine, Obstetrics & Gynecology, and Community Health Sciences Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey","family":"McLaughlin","sequence":"additional","affiliation":[{"name":"Departments of Obstetrics and Gynecology, Sinai Health Systems and University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia M.","family":"Grandi","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Ontario, Canada"},{"name":"Child Health Evaluative Sciences Program, The Hospital for Sick Children, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella S.","family":"Daskalopoulou","sequence":"additional","affiliation":[{"name":"Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada"},{"name":"Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Metcalfe","sequence":"additional","affiliation":[{"name":"Departments of Medicine, Obstetrics & Gynecology, and Community Health Sciences Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,10,3]]},"reference":[{"issue":"3","key":"zoi241073r1","doi-asserted-by":"publisher","first-page":"B17","DOI":"10.1016\/j.ajog.2016.07.050","article-title":"Severe maternal morbidity: screening and review.","volume":"215","author":"Kilpatrick","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"zoi241073r2","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/ppe.12574","article-title":"Severe maternal morbidity surveillance: monitoring pregnant women at high risk for prolonged hospitalisation and death.","volume":"34","author":"Dzakpasu","year":"2020","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"2","key":"zoi241073r4","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/GRF.0000000000000349","article-title":"Reducing disparities in severe maternal morbidity and mortality.","volume":"61","author":"Howell","year":"2018","journal-title":"Clin Obstet Gynecol"},{"issue":"1","key":"zoi241073r6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12884-015-0789-4","article-title":"Constructing maternal morbidity - towards a standard tool to measure and monitor maternal health beyond mortality.","volume":"16","author":"Chou","year":"2016","journal-title":"BMC Pregnancy Childbirth"},{"issue":"18","key":"zoi241073r8","doi-asserted-by":"publisher","first-page":"423","DOI":"10.15585\/mmwr.mm6818e1","article-title":"Vital signs: pregnancy-related deaths, United States, 2011-2015, and Strategies for Prevention, 13 States, 2013-2017.","volume":"68","author":"Petersen","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"zoi241073r10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2022.100121","article-title":"Cardiovascular severe maternal morbidity and mortality at delivery in the United States: a population-based study.","volume":"1","author":"Malham\u00e9","year":"2022","journal-title":"JACC Adv"},{"issue":"4","key":"zoi241073r11","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1097\/AOG.0000000000003497","article-title":"ACOG Practice Bulletin No. 212: pregnancy and heart disease.","volume":"134","author":"Moussa","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"5","key":"zoi241073r12","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1097\/AOG.0000000000001981","article-title":"Maternal cardiovascular mortality in Illinois, 2002-2011.","volume":"129","author":"Briller","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"4","key":"zoi241073r13","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/ppe.12571","article-title":"Identifying cardiovascular severe maternal morbidity in epidemiologic studies.","volume":"34","author":"Malham\u00e9","year":"2020","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"2","key":"zoi241073r14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2023.100275","article-title":"Assessment and prediction of cardiovascular contributions to severe maternal morbidity.","volume":"2","author":"Thakkar","year":"2023","journal-title":"JACC Adv"},{"issue":"5","key":"zoi241073r15","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/1471-0528.16512","article-title":"Cardiovascular severe maternal morbidity in pregnant and postpartum women: development and internal validation of risk prediction models.","volume":"128","author":"Malham\u00e9","year":"2021","journal-title":"BJOG"},{"issue":"5","key":"zoi241073r16","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.cjca.2018.02.021","article-title":"Hypertension Canada\u2019s 2018 Guidelines for the Management of Hypertension in Pregnancy.","volume":"34","author":"Butalia","year":"2018","journal-title":"Can J Cardiol"},{"issue":"1","key":"zoi241073r17","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s12884-021-03809-2","article-title":"Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and national levels: a population-based study.","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Pregnancy Childbirth"},{"issue":"26","key":"zoi241073r18","doi-asserted-by":"publisher","first-page":"E897","DOI":"10.1503\/cmaj.231547","article-title":"Trends in rate of hypertensive disorders of pregnancy and associated morbidities in Canada: a population-based study (2012-2021).","volume":"196","author":"Dzakpasu","year":"2024","journal-title":"CMAJ"},{"issue":"2","key":"zoi241073r19","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.023791","article-title":"Trends in the incidence of new-onset hypertensive disorders of pregnancy among rural and urban areas in the United States, 2007 to 2019.","volume":"11","author":"Cameron","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"9499","key":"zoi241073r20","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1016\/S0140-6736(05)67726-4","article-title":"Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study.","volume":"366","author":"Ray","year":"2005","journal-title":"Lancet"},{"issue":"8","key":"zoi241073r21","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1161\/CIRCULATIONAHA.118.036748","article-title":"Cardiovascular disease-related morbidity and mortality in women with a history of pregnancy complications.","volume":"139","author":"Grandi","year":"2019","journal-title":"Circulation"},{"issue":"4","key":"zoi241073r22","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1097\/AOG.0000000000000173","article-title":"Frequency of and factors associated with severe maternal morbidity.","volume":"123","author":"Grobman","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"11","key":"zoi241073r23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0294140","article-title":"Ranked severe maternal morbidity index for population-level surveillance at delivery hospitalization based on hospital discharge data.","volume":"18","author":"Kuklina","year":"2023","journal-title":"PLoS One"},{"issue":"2S","key":"zoi241073r26","doi-asserted-by":"publisher","first-page":"S876","DOI":"10.1016\/j.ajog.2020.07.038","article-title":"Does race or ethnicity play a role in the origin, pathophysiology, and outcomes of preeclampsia? an expert review of the literature.","volume":"226","author":"Johnson","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"zoi241073r27","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s10995-007-0256-6","article-title":"An enhanced method for identifying obstetric deliveries: implications for estimating maternal morbidity.","volume":"12","author":"Kuklina","year":"2008","journal-title":"Matern Child Health J"},{"issue":"4","key":"zoi241073r28","doi-asserted-by":"publisher","first-page":"422.e1","DOI":"10.1016\/j.ajog.2021.03.036","article-title":"Impact of the ICD-9-CM to ICD-10-CM transition on the incidence of severe maternal morbidity among delivery hospitalizations in the United States.","volume":"225","author":"Metcalfe","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"zoi241073r29","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1097\/01.AOG.0000437382.03963.88","article-title":"Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy.","volume":"122","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"19","key":"zoi241073r30","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1136\/heartjnl-2021-320684","article-title":"Pregnancy-related cardiovascular conditions and outcomes in a United States Medicaid population.","volume":"108","author":"Marschner","year":"2022","journal-title":"Heart"},{"issue":"5","key":"zoi241073r32","doi-asserted-by":"publisher","first-page":"643.e1","DOI":"10.1016\/j.ajog.2015.11.004","article-title":"Measuring severe maternal morbidity: validation of potential measures.","volume":"214","author":"Main","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"38","key":"zoi241073r33","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1093\/eurheartj\/ehac308","article-title":"Hypertensive disorders of pregnant women with heart disease: the ESC EORP ROPAC Registry.","volume":"43","author":"Ramlakhan","year":"2022","journal-title":"Eur Heart J"},{"issue":"9","key":"zoi241073r34","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1007\/s10554-020-01866-w","article-title":"The spectrum of pregnancy-associated heart failure phenotypes: an echocardiographic study.","volume":"36","author":"Lindley","year":"2020","journal-title":"Int J Cardiovasc Imaging"},{"issue":"18","key":"zoi241073r35","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/j.jacc.2013.08.717","article-title":"The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis.","volume":"62","author":"Bello","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"zoi241073r36","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.preghy.2019.05.014","article-title":"Peripartum cardiomyopathy with co-incident preeclampsia: a cohort study of clinical risk factors and outcomes among commercially insured women.","volume":"17","author":"Malham\u00e9","year":"2019","journal-title":"Pregnancy Hypertens"},{"issue":"6","key":"zoi241073r37","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/j.1365-2044.2012.07055.x","article-title":"Acute pulmonary oedema in pregnant women.","volume":"67","author":"Dennis","year":"2012","journal-title":"Anaesthesia"},{"issue":"4","key":"zoi241073r38","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1177\/1753495X19825699","article-title":"Neurovascular disorders in pregnancy: A review.","volume":"12","author":"Roth","year":"2019","journal-title":"Obstet Med"},{"issue":"4","key":"zoi241073r40","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1213\/ANE.0000000000004203","article-title":"Stroke in pregnancy: a focused update.","volume":"130","author":"Miller","year":"2020","journal-title":"Anesth Analg"},{"issue":"3","key":"zoi241073r41","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1097\/01.AOG.0000172428.78411.b0","article-title":"Incidence and risk factors for stroke in pregnancy and the puerperium.","volume":"106","author":"James","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"6","key":"zoi241073r42","doi-asserted-by":"publisher","first-page":"582.e1","DOI":"10.1016\/j.ajog.2019.02.010","article-title":"Severe cardiovascular morbidity in women with hypertensive diseases during delivery hospitalization.","volume":"220","author":"Ackerman","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"zoi241073r43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.preghy.2021.11.003","article-title":"Inappropriate left ventricular mass after HELLP syndrome inappropriate LVM after HELLP syndrome.","volume":"27","author":"Sciatti","year":"2022","journal-title":"Pregnancy Hypertens"},{"issue":"6","key":"zoi241073r45","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1002\/uog.20407","article-title":"Reduced coronary flow velocity reserve in women with previous pre-eclampsia: link to increased cardiovascular disease risk.","volume":"55","author":"Clemmensen","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"zoi241073r46","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1148\/radiology.217.2.r00nv44371","article-title":"Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy.","volume":"217","author":"Schwartz","year":"2000","journal-title":"Radiology"},{"issue":"1","key":"zoi241073r47","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s12884-020-03017-4","article-title":"Severe pre-eclamptic women with headache: is posterior reversible encephalopathy syndrome an associated concurrent finding?","volume":"20","author":"Chao","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"issue":"2","key":"zoi241073r48","doi-asserted-by":"publisher","first-page":"239.e1","DOI":"10.1016\/j.ajog.2016.02.039","article-title":"Incidence of posterior reversible encephalopathy syndrome in eclamptic and patients with preeclampsia with neurologic symptoms.","volume":"215","author":"Mayama","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"zoi241073r49","doi-asserted-by":"publisher","first-page":"468.e1","DOI":"10.1016\/j.ajog.2013.02.015","article-title":"Posterior reversible encephalopathy syndrome in 46 of 47 patients with eclampsia.","volume":"208","author":"Brewer","year":"2013","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"zoi241073r50","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/AOG.0000000000003319","article-title":"Predictive model of factors associated with maternal intensive care unit admission.","volume":"134","author":"Rossi","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"3","key":"zoi241073r51","doi-asserted-by":"publisher","first-page":"271.e1","DOI":"10.1016\/j.ajog.2019.06.025","article-title":"A comorbidity-based screening tool to predict severe maternal morbidity at the time of delivery.","volume":"221","author":"Easter","year":"2019","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"zoi241073r52","doi-asserted-by":"publisher","first-page":"B19","DOI":"10.1016\/j.ajog.2019.05.046","article-title":"Obstetric Care Consensus #9: Levels of Maternal Care: (Replaces Obstetric Care Consensus Number 2, February 2015).","volume":"221","author":"Kilpatrick","year":"2019","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"zoi241073r53","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1097\/AOG.0b013e31826af878","article-title":"Maternal mortality, near misses, and severe morbidity: lowering rates through designated levels of maternity care.","volume":"120","author":"Hankins","year":"2012","journal-title":"Obstet Gynecol"},{"key":"zoi241073r3","first-page":"1029","volume-title":"Obstet Gynecol","author":"Callaghan","year":"2012"},{"key":"zoi241073r39","author":"Malham\u00e9","year":"2021"},{"key":"zoi241073r44","volume-title":"Clin Sci (Lond)","author":"Stanhewicz","year":"2021"},{"key":"zoi241073r5","unstructured":"CDC. Severe maternal morbidity in the United States. Accessed April 17, 2023. https:\/\/www.cdc.gov\/reproductivehealth\/maternalinfanthealth\/severematernalmorbidity.html#anchor_trends"},{"key":"zoi241073r7","unstructured":"Marian Knight? KB. Derek Tuffnell, Judy Shakespeare, Rohit Kotnis SK, Jennifer J Kurinczuk (Eds.). Saving Lives, Improving Mothers\u2019 Care. Accessed June 10, 2021. https:\/\/www.npeu.ox.ac.uk\/assets\/downloads\/mbrrace-uk\/reports\/maternal-report-2020\/MBRRACE-UK_Maternal_Report_Dec_2020_v10_ONLINE_VERSION_1404.pdf"},{"key":"zoi241073r9","unstructured":"CDC. Pregnancy Mortality Surveillance System. May 18, 2021. Accessed September 4, 2024. https:\/\/www.cdc.gov\/maternal-mortality\/php\/pregnancy-mortality-surveillance\/index.html"},{"key":"zoi241073r24","unstructured":"Agency for Healthcare Research and Quality. Rockville, MD. HCUP Databases. Healthcare Cost and Utilization Project (HCUP). Accessed July 25, 2024. https:\/\/hcup-us.ahrq.gov\/nisoverview.jsp#data"},{"key":"zoi241073r25","unstructured":"HCUP NIS Description of Data Elements. Healthcare Cost and Utilization Project (HCUP). September 2008. Agency for Healthcare Research and Quality, Rockville, MD. Accessed July 30, 2024. http:\/\/www.hcup-us.ahrq.gov\/db\/vars\/race\/nisnote.jsp"},{"key":"zoi241073r31","unstructured":"Division of Reproductive Health National Center for Chronic Disease Prevention and Health Promotion. How does CDC identify severe maternal morbidity? July 10, 2023. Accessed July 10, 2023. https:\/\/www.cdc.gov\/reproductivehealth\/maternalinfanthealth\/smm\/severe-morbidity-ICD.htm"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2824356\/malham_2024_oi_241073_1727378207.96288.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T11:32:18Z","timestamp":1727955138000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2824356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,3]]},"references-count":53,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.36478","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,3]]}}}